Integrated Eye Tracking and Neural Monitoring for TBI: Optimization
NCT ID: NCT03451058
Last Updated: 2022-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
138 participants
OBSERVATIONAL
2017-07-07
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oculomotor Assessment of Traumatic Brain Injury (TBI)
NCT03156010
Eye Movement Recordings in the Diagnosis of Traumatic Brain Injury
NCT00875589
Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
NCT03319966
Assessment of Oculomotor, Vestibular and Reaction Time Response Following a Concussive Event
NCT01832714
Use of Eye Movement Tracking to Detect Oculomotor Abnormality in Traumatic Brain Injury Patients
NCT02776462
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In general, participants will provide demographic information, medical history, and details of their head injury. Participants will also complete a brief neuropsychological assessment to obtain an index of cognitive ability, along with the Fusion Test with eye tracking and linked EEG. MRI data may also be obtained.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mild TBI Group
History of head injury, Active Duty Service Member or Veteran, age 18-55, fluent in English
No interventions assigned to this group
Moderate to Severe TBI Group
History of head injury, Active Duty Service Member or Veteran, age 18-55, fluent in English
No interventions assigned to this group
Healthy Controls
No history of head injury, Active Duty Service Member or Veteran, age 18-55, fluent in English
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to use dominant hand to complete cognitive and motor tasks
* Fluent in English
Mild TBI group:
* History of mild TBI \> 3 months and \< 10 years prior to enrollment
* Self-report of post-concussive symptoms
Moderate-to-Severe TBI group:
\- History of moderate or severe TBI \> 3 months and \< 10 years prior to enrollment
Exclusion Criteria
History of possible or confirmed brain injury
All groups:
* History of a medical condition (other than brain injury) that would be expected to affect cognitive or motor abilities (e.g. muscular dystrophy, multiple sclerosis, or psychotic disorders such as schizophrenia)
* Presence of neurological condition, such as brain tumor, brain infection, seizure, or stroke
* Presence of visual impairment that is uncorrected by glasses or contacts (including color blindness)
* Evidence of current suicidal or homicidal ideation
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uniformed Services University of the Health Sciences
FED
The Defense and Veterans Brain Injury Center
FED
United States Naval Medical Center, San Diego
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lynita Mullins
Department Head, Physical Medicine and Rehabilitation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Naval Medical Center San Diego
San Diego, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NMCSD.2017.0012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.